Brief: CK Life Sciences Intl (Holdings) Posts HY Profit Attributable Of HK$171.3 Mln
July 30 (Reuters) - CK Life Sciences Intl (Holdings) Inc
0775.HK :
* HY REVENUE HK$2.60 BILLION VERSUS HK$2.54 BILLION
* HY PROFIT ATTRIBUTABLE HK$171.3 MILLION VERSUS HK$170.9
MILLION
Source text for Eikon: ID:nHKS4cYNHP
Further company coverage: 0775.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CK Life Sciences Intl (Holdings)
See all newsCK Life Sciences H1 loss narrows on lower R&D costs
Brief: CK Life Sciences Intl Announces Resignation Of Lance Richard Lee Yuen As Executive Director, CEO
Brief: CK Life Sciences Intl Logs FY Loss Attributable HK$186.8 Mln
CK Life Sciences rises most in 4 months on advancing cancer vaccine development
Brief: CK Life Sciences Intl Establishes Sequencio Therapeutics For Cancer Vaccine Development